Literature DB >> 20035918

A unique solution to solve the pending medical school tuition crisis.

Louis Weinstein1, Honor Wolfe.   

Abstract

The increasing cost of undergraduate medical education and the decreasing availability of financial aid have resulted in the accumulation of a large debt for medical students that requires a reasonable solution. After reviewing suggested solutions to alleviate medical student debt, we have developed a unique proposal. The Strategic Alternative for Funding Education (SAFE) has the practicing physician pay for his or her medical school education after completion of residency/fellowship over a 10-year time interval when income will likely be rising. The amount paid yearly is calculated as a percent of the physician's professional income. A strategic alternative for funding education has the potential to alleviate the pending crisis in medical student debt, allows medical schools to compete for students based on the educational experience offered, and allows a student of any socioeconomic status to attend medical school and choose a medical specialty based solely on ability and desire. Copyright (c) 2010 Mosby, Inc. All rights reserved.

Mesh:

Year:  2009        PMID: 20035918     DOI: 10.1016/j.ajog.2009.11.019

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  2 in total

1.  An update on finances and financial support for medical students in Yong Loo Lin School of Medicine.

Authors:  Andrew Arjun Sayampanathan; Yeong Tze Wilnard Tan; Jie Ming Nigel Fong; Yun Qing Koh; Chew Lip Ng; Niraj Mohan; Jin Hao Justin Jang; Paul Anantharajah Tambyah
Journal:  Singapore Med J       Date:  2016-08-12       Impact factor: 1.858

2.  Financial burden and financial aid for medical students in Singapore: a national survey across all three medical schools.

Authors:  Yeong Tze Wilnard Tan; Andrew Arjun Sayampanathan; Kannan Chidambaram; Yun Qing Koh; Jie Ming Nigel Fong; Jinrong Ivan Low; Chew Lip Ng; Paul Ananth Tambyah
Journal:  Singapore Med J       Date:  2020-06-02       Impact factor: 3.331

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.